New InsiGHTS Trial of TransCon® hGH (Lonapegsomatropin) in Turner Syndrome Demonstrated Comparable Efficacy and Safety to Daily Somatropin at Week 52

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/9/2026

1. USO
2. COST
3. SPY
4. RMR
5. MSFT
6. RXT
7. IBM
8. HOOD
9. META
10. LEVI

Go back to New InsiGHTS Trial of TransCon® hGH (Lonapegsomatropin) in Turner Syndrome Demonstrated Comparable Efficacy and Safety to Daily Somatropin at Week 52
Asianada, Inc. (NASDAQ: ASND) Delayed: 277.18 --0 (-0%)
Previous Close $277.18    52 Week High $21.79 
Open $277.18    52 Week Low $11.92 
Day High $277.18    P/E N/A 
Day Low $277.18    EPS $-0.07 
Volume 54